The ALBI grade refines prognostic prediction in advanced hepatocellular cancer and enables risk stratification for bleeding events following atezolizumab plus bevacizumab Antonio D'Alessio , Claudia Fulgenzi , Bernhard Scheiner , James Korolewicz , Jaekyung Cheon , Naoshi Nishida , Celina Ang , Thomas Marron , Linda Wu , Anwaar Saeed , Brooke Wietharn , Antonella Cammarota , Tiziana Pressiani , Matthias Pinter , Lorenz Balcar , Yi-Hsiang Huang , Aman Mehan , Samuel Phen , Caterina Vivaldi , Francesca Salani , Gianluca Masi , Dominik Bettinger , Arndt Vogel , Martin Schoenlein , Johann von Felden , Kornelius Schulze , Henning Wege , Adel Samson , Peter Galle , Masatoshi Kudo , Alessio Cortellini , Amit Singal , Lorenza Rimassa , Rohini Sharma , Hong Jae Chon , David J. Pinato JOURNAL OF HEPATOLOGY（2023）
关键词
advanced hepatocellular cancer, albi grade, prognostic prediction, atezolizumab
AI 理解论文
溯源树
样例
